ENVARSUS

This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Lithuania, Netherlands, Poland, United Kingdom, United States

Active ingredients

The drug ENVARSUS contains one active pharmaceutical ingredient (API):

1 Tacrolimus monohydrate UNII WM0HAQ4WNM - TACROLIMUS

Tacrolimus is a highly potent immunosuppressive agent. In particular, tacrolimus inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection. Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor. Read about Tacrolimus

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AD02	Tacrolimus	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AD Calcineurin inhibitors
Discover more medicines within L04AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02485877, 02485885, 02485893
Country: EE	Ravimiamet	Identifier(s): 1661105, 1661116, 1661127, 1661138, 1661149, 1661150, 1661161, 1661172, 1661183
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114935001, 114935004, 114935005, 114935007
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 148850, 149842, 523227
Country: FR	Base de données publique des médicaments	Identifier(s): 64349915, 65037007, 69590806
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 287919, 287922, 287925
Country: IE	Health Products Regulatory Authority	Identifier(s): 88551, 88552, 88553
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1074012, 1074013, 1074014, 1074015, 1074016, 1074017, 1074018, 1074019, 1074020
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 120030, 120049, 120057
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100325845, 100325851, 100325868
Country: US	FDA, National Drug Code	Identifier(s): 68992-3010, 68992-3040, 68992-3075